Antiviral Efficacy of Coridothymus capitatus Essential Oil Against HSV-1 and HSV-2

被引:0
|
作者
Fuochi, Virginia [1 ]
Furneri, Pio Maria [1 ]
Furnari, Salvatore [1 ]
Garozzo, Adriana [1 ]
机构
[1] Univ Catania, Dipartimento Sci Biomed & Biotecnol BIOMETEC, I-95030 Catania, Italy
来源
LIFE-BASEL | 2024年 / 14卷 / 08期
关键词
Coridothymus capitatus; essential oil; carvacrol; antiviral activity; HSV-1; HSV-2; natural antiviral agents; viral replication; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; IN-VITRO; L; CAV; CARVACROL; THYMOL; ANTIBACTERIAL; WILD; POPULATIONS; SARS-COV-2;
D O I
10.3390/life14081023
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Coridothymus capitatus is a perennial herb with aromatic leaves and flowers, distinct from Thymus vulgaris in its chemical composition, resulting in a unique Thymus Essential Oil (TEO). A main component of TEO, carvacrol, is known for its antimicrobial and insecticidal activity. Carvacrol has potent antibacterial, antioxidant, anti-inflammatory, and antifungal properties, generating interest in traditional medicine. However, studies on its antiviral activity are limited. Given the rise in viral infections and limitations of synthetic antiviral drugs, natural antiviral agents are promising due to their efficacy, lower resistance development, and reduced side effects. This study assessed the antiviral efficacy of TEO compared to that of pure carvacrol. We tested various viruses, revealing significant inhibitory effects of TEO on the replication of only Simplexvirus humanalpha1 (HSV-1) and Simplexvirus humanalpha2 (HSV-2), with specific interference during the early stages of the viral replication cycle after the adsorption period. TEO exhibited inhibitory effects at doses below the cytotoxic threshold, with IC50 values of 47 mu g/mL for HSV-1 and 40 mu g/mL for HSV-2. Maximum virus inhibition was achieved when TEO was added within 90 min post-infection, indicating interference with early viral replication steps. These findings highlight the potential of TEO as a natural antiviral agent and suggest further research into its mechanisms and clinical applications.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing
    Crawford, Katharine H. D.
    Selke, Stacy
    Pepper, Gregory
    Goecker, Erin
    Sobel, Aniela
    Wald, Anna
    Johnston, Christine
    Greninger, Alexander L.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2024, 62 (06)
  • [22] ENHANCEMENT AND SUPPRESSION OF HSV-1 AND HSV-2 INDUCED ANTIBODY-FORMATION
    NICK, S
    METZGER, B
    KNOBLICH, A
    KAMPE, P
    FALKE, D
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1987, 264 (1-2): : 267 - 267
  • [23] Serological microarray for detection of HSV-1, HSV-2, VZV, and CMV antibodies
    Jaaskelainen, Anne J.
    Moilanen, Kirsi
    Buhler, Suvi
    Lappalainen, Maija
    Vapalahti, Olli
    Vaheri, Antti
    Piiparinen, Heli
    JOURNAL OF VIROLOGICAL METHODS, 2009, 160 (1-2) : 167 - 171
  • [24] Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs
    Yadavalli, Tejabhiram
    Mallick, Sudipta
    Patel, Pratikkumar
    Koganti, Raghuram
    Shukla, Deepak
    Date, Abhijit A.
    ACS INFECTIOUS DISEASES, 2020, 6 (11): : 2926 - 2937
  • [25] Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
    Boukhvalova, Marina
    McKay, Jamall
    Mbaye, Aissatou
    Sanford-Crane, Hannah
    Blanco, Jorge C. G.
    Huber, Ashley
    Herold, Betsy C.
    JOURNAL OF VIROLOGY, 2015, 89 (19) : 9825 - 9840
  • [26] Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
    Clare Burn Aschner
    David M. Knipe
    Betsy C. Herold
    npj Vaccines, 5
  • [27] Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
    Burn Aschner, Clare
    Knipe, David M.
    Herold, Betsy C.
    NPJ VACCINES, 2020, 5 (01)
  • [28] A TRANSFORMING PLASMID FROM HSV-2 TRANSFORMED-CELLS CONTAINS RAT DNA HOMOLOGOUS TO THE HSV-1 AND HSV-2 GENOMES
    BEJCEK, B
    CONLEY, AJ
    VIROLOGY, 1986, 154 (01) : 41 - 55
  • [29] PASSIVE TRANSFER OF ANTI-HSV-2 MONOCLONAL AND POLYCLONAL ANTIBODIES PROTECT AGAINST HSV-1 BUT NOT HSV-2 INDUCED STROMAL KERATITIS
    RITCHIE, MH
    OAKES, JE
    LAUSCH, RN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1135 - 1135
  • [30] Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)in vitro
    Su -Yun Lyu
    Jee -Young Rhim
    Won -Bong Park
    Archives of Pharmacal Research, 2005, 28 : 1293 - 1301